Cipriani, C.; Pacheco, M.P.; Kishk, A.; Wachich, M.; Abankwa, D.; Schaffner-Reckinger, E.; Sauter, T.
Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay. Pharmaceuticals 2022, 15, 179.
https://doi.org/10.3390/ph15020179
AMA Style
Cipriani C, Pacheco MP, Kishk A, Wachich M, Abankwa D, Schaffner-Reckinger E, Sauter T.
Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay. Pharmaceuticals. 2022; 15(2):179.
https://doi.org/10.3390/ph15020179
Chicago/Turabian Style
Cipriani, Claudia, Maria Pires Pacheco, Ali Kishk, Maryem Wachich, Daniel Abankwa, Elisabeth Schaffner-Reckinger, and Thomas Sauter.
2022. "Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay" Pharmaceuticals 15, no. 2: 179.
https://doi.org/10.3390/ph15020179
APA Style
Cipriani, C., Pacheco, M. P., Kishk, A., Wachich, M., Abankwa, D., Schaffner-Reckinger, E., & Sauter, T.
(2022). Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay. Pharmaceuticals, 15(2), 179.
https://doi.org/10.3390/ph15020179